Skip to Content
View Additional Content In This Section
Thrombolytic medicines, such as streptokinase or
tissue-type plasminogen activator (t-PA), interfere with the action of
thrombin, which is needed to form blood clots. These medicines help to dissolve
blood clots and may be used to treat
pulmonary embolism in life-threatening situations.
All thrombolytics can cause serious bleeding. Bleeding
inside the brain is a particular danger that can cause a stroke or death. In
general, thrombolytics are used only where the risk of bleeding can be balanced
against the risks of not dissolving the blood clot rapidly. Thrombolytics might be used when you have a large blood clot that is:
These medicines are given through a vein in the hand or arm.
Sometimes it is necessary to insert a catheter and give the medicine
directly into the pulmonary artery. You must be hospitalized to receive
Other Works Consulted
Guyatt GH, et al. (2012). Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed.—American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 141(2, Suppl): 7S–47S.
Kearon C, et al. (2012). Antithrombotic therapy for VTE disease. Chest, 141(2, Suppl): e419S–e494S.
Weitz JI (2012). Pulmonary embolism. In L Goldman, A Shafer, eds., Goldman's Cecil Medicine, 24th ed., pp. 596–603. Philadelphia: Saunders.
ByHealthwise StaffPrimary Medical ReviewerE. Gregory Thompson, MD - Internal MedicineSpecialist Medical ReviewerJeffrey S. Ginsberg, MD - Hematology
Current as ofAugust 21, 2015
Current as of:
August 21, 2015
E. Gregory Thompson, MD - Internal Medicine & Jeffrey S. Ginsberg, MD - Hematology
To learn more about Healthwise, visit Healthwise.org.
© 1995-2015 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.